IFNG and lung carcinoma: A phenotypical and functional analysis of TANs in early-stage lung cancer found an activated phenotype (CD62lowCD54high) that was able to stimulate T cell proliferation and IFN-γ release, which suggested a pro-inflammatory rather than immunosuppressive state of TANs in early-stage lung cancer (88).